ResearcherGerman Cancer Research CenterActive in the last 2 years
Madeleine Dorsch
Matched on ORCID iD 0000-0002-5998-4177; OpenAlex author ID A5061886741. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer Co-author DOI 10.64898/2026.10.06.756936↗
- PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.115541↗
- Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. First author DOI 10.1038/s41598-018-32159-x↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Barbara M. Grüner · 3 shared papers, 2018–2026 · strength 0.48
- Paper PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. DOI 10.1016/j.celrep.2025.115541↗
- Paper Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic canc… DOI 10.64898/2026.10.06.756936↗
- Paper Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. DOI 10.1038/s41598-018-32159-x↗
- Laura Godfrey · 2 shared papers, 2025–2026 · strength 0.40
- Jens Thomas Siveke · 2 shared papers, 2025–2026 · strength 0.40
- Rui Fang · 1 shared paper, 2025 · strength 0.20
- Marija Trajkovic‐Arsic · 1 shared paper, 2025 · strength 0.20
- Hendrik Schürmann · 1 shared paper, 2025 · strength 0.20
- Stephan A. Hahn · 1 shared paper, 2025 · strength 0.20
- Ben Zhao · 1 shared paper, 2025 · strength 0.20
- Smiths Lueong · 1 shared paper, 2025 · strength 0.20
- Barbara T. Grünwald · 1 shared paper, 2026 · strength 0.20
- Kazeera Aliar · 1 shared paper, 2026 · strength 0.20
- Günter Schneider · 1 shared paper, 2026 · strength 0.20
- John P. Neoptolemos · 1 shared paper, 2026 · strength 0.20
- Elisabeth Heßmann · 1 shared paper, 2026 · strength 0.20
- Faiyaz Notta · 1 shared paper, 2026 · strength 0.20
- Albert C. Koong · 1 shared paper, 2018 · strength 0.09
- Shin‐Heng Chiou · 1 shared paper, 2018 · strength 0.09
- Margaret M. Kozak · 1 shared paper, 2018 · strength 0.09
- Monte Meier Winslow · 1 shared paper, 2018 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.